Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3068% below fair value
$3.86−0.31 (-7.43%)
Close on Nov 12, 2026Market cap $72.56MP/E –Yield –
Outset Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Outset Medical's ebitda for the twelve months ending Sep 30, 2026 was -$59.52M. For fiscal 2025 it was -$62.37M. The highest annual figure on record is -$45.49M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$62.37M | – |
| FY2024 | Dec 31, 2024 | -$107.65M | – |
| FY2023 | Dec 31, 2023 | -$163.96M | – |
| FY2022 | Dec 31, 2022 | -$155.85M | – |
| FY2021 | Dec 31, 2021 | -$125.36M | – |
| FY2020 | Dec 31, 2020 | -$114.31M | – |
| FY2019 | Dec 31, 2019 | -$68.82M | – |
| FY2018 | Dec 31, 2018 | -$45.49M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$11.60M | – |
| Q2 FY2026 | Jun 30, 2026 | -$15.05M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.12M | – |
| Q4 FY2025 | Dec 31, 2025 | -$16.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$14.80M | – |
| Q2 FY2025 | Jun 30, 2025 | -$15.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.11M | – |
| Q4 FY2024 | Dec 31, 2024 | -$20.45M | – |
| Q3 FY2024 | Sep 30, 2024 | -$22.45M | – |
| Q2 FY2024 | Jun 30, 2024 | -$29.29M | – |
| Q1 FY2024 | Mar 31, 2024 | -$35.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$35.91M | – |
| Q3 FY2023 | Sep 30, 2023 | -$43.99M | – |
| Q2 FY2023 | Jun 30, 2023 | -$41.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$42.10M | – |
| Q4 FY2022 | Dec 31, 2022 | -$38.56M | – |
| Q3 FY2022 | Sep 30, 2022 | -$39.69M | – |
| Q2 FY2022 | Jun 30, 2022 | -$42.40M | – |
| Q1 FY2022 | Mar 31, 2022 | -$35.21M | – |
| Q4 FY2021 | Dec 31, 2021 | -$39.50M | – |
| Q3 FY2021 | Sep 30, 2021 | -$28.83M | – |
| Q2 FY2021 | Jun 30, 2021 | -$28.60M | – |
| Q1 FY2021 | Mar 31, 2021 | -$28.43M | – |
| Q4 FY2020 | Dec 31, 2020 | -$29.69M | – |
| Q3 FY2020 | Sep 30, 2020 | -$40.19M | – |
| Q2 FY2020 | Jun 30, 2020 | -$24.53M | – |
| Q1 FY2020 | Mar 31, 2020 | -$19.91M | – |
| Q4 FY2019 | Dec 31, 2019 | -$18.20M | – |
See a number that looks wrong?